Search Results

You searched for : anti-CD3

	Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of ... Sep 15
	Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab Latest pharma Update... Sep 06
	Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma ... Jun 25
	Teneobio received US FDA clearance of investigational new drug application and the initiation of phase I clinical studies in patients with B-cell malignancies TNB-486 induced T-cell dependent killing of CD19-positive B-cell leukemia and lymphoma cells while inducing minimal cytokine secretion... Oct 05
	Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) platform exclusive license from Sorento... Sep 15
	AGC Biologics completes PPQ manufacturing campaign with Provention Bio for , Teplizumab Teplizumab, Provention Bioâ€™s lead drug candidate, is an anti-CD3 monoclonal antibody (mAb) being developed for the delay or prevention of type 1 diabetes ... Aug 29
	FDA approves GSKâ€™s BLENREP (belantamab mafodotin) for myleoma FDA approves GSKâ€™s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma... Aug 07
	EU approves Bristol Myers Squibbâ€™s Idecabtagene Vicleucel and CC-486 Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
8 Matching result(s) found!

-Advertisements-

Trending Now
	ALARM 2024: Amrita Leads the Fight Against Antimicrobial ResistanceDecember 02, 2024
	Coral adaptation unlikely to keep pace with global warmingDecember 02, 2024
	Reaching the unreached to find missing TB casesDecember 02, 2024
	Sip Smart: Why Changing Your Water Habits Can Change Your LifeNovember 28, 2024
	Can Your Fingers Predict How Much You Drink? New Study ExplainsNovember 28, 2024
	India Leads Global Medical Tourism with 8% Share; PSRI Sets New Benchmarks with nearly 15% International Patient BaseNovember 28, 2024
	Medicines save lives but not when they stop workingNovember 28, 2024
	A total of 340 Children Participated in the Painting Competition Organized by Asian HospitalNovember 28, 2024
	The Standing Desk Myth: Is Sitting Actually Healthier?November 27, 2024
	How Cancer Outsmarts Chemotherapy: The Hidden Metabolic GameNovember 27, 2024
	Aakash Healthcare Saves life of a 61-year-old Women through Timely Neuro-intervention with a multi-disciplinary management of StrokeNovember 27, 2024
	Breakfast Wars: Why Men and Women Should Eat DifferentlyNovember 27, 2024
	Only 10% of Businesses Are Ready to Become Experience-Orchestrated, Highlighting Lack of PersonalisationNovember 27, 2024
	Investors Think Safe, but Act Bold: MyFi Report Exposes Risk Tolerance Mismatch November 27, 2024
	Indkal Technologies Redefines Luxury Home Entertainment with Acer M Series Hybrid MiniLED TelevisionsNovember 27, 2024
	Fat’s Double-Edged Sword: How It Protects and Betrays Your HealthNovember 27, 2024
	Decoding the Brain: How Understanding Social Networks in the Mind Could Revolutionize Mental Health TreatmentNovember 26, 2024
	M-Pox Crisis: The Global Emergency We Can’t IgnoreNovember 26, 2024
	From 3% Survival Odds to Cancer-Free: How Navjot Kaur Sidhu Defied Cancer with a Holistic LifestyleNovember 25, 2024
	Pills Without Prescriptions: How Antibiotic Misuse is Fuelling a Public Health Crisis in MumbaiNovember 25, 2024

Search Results

Nasal Immunotherapy Shows Promise in Reducing Inflammation and Boosting Cognitive Function in Alzheimer's Disease

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma

Teneobio received US FDA clearance of investigational new drug application and the initiation of phase I clinical studies in patients with B-cell malignancies

Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug

AGC Biologics completes PPQ manufacturing campaign with Provention Bio for , Teplizumab

FDA approves GSKâ€™s BLENREP (belantamab mafodotin) for myleoma

EU approves Bristol Myers Squibbâ€™s Idecabtagene Vicleucel and CC-486

Trending Now